1. Azathioprine: risk of erythema nodosum, safety alert issued in Malaysia

   News item 30 July 2022 Pages: 1 - 1

2. Chloroquine, hydroxychloroquine: risk of psychiatric disorders

   News item 30 July 2022 Pages: 2 - 2

3. Cholinesterase inhibitors: risk of QT-interval prolongation, torsade de pointes

   News item 30 July 2022 Pages: 3 - 3

4. COVID-19 vaccination: reports of Bell's palsy

   News item 30 July 2022 Pages: 4 - 4

5. First-generation antihistamines not to be used in young children for cough, cold, `flu

   News item 30 July 2022 Pages: 5 - 5

6. Recall of magnesium citrate oral solution products in Canada due to potential contamination

   News item 30 July 2022 Pages: 6 - 6

7. Amphotericin B toxicity higher in children aged ≥ 13 months than in younger children

   Clinical study 30 July 2022 Pages: 7 - 7

8. COVID-19 vaccine: risk of increased menstrual bleeding

   Clinical study 30 July 2022 Pages: 8 - 8

9. Gabapentinoid dosing often inappropriate in CKD, no association with AEs

   Clinical study 30 July 2022 Pages: 9 - 9

10. New approach for detecting MedDRA-coded AEs in RCTs

    Clinical study 30 July 2022 Pages: 10 - 10

11. Safety of COVID-19 mRNA vaccine first booster doses among immunocompromised persons

    Clinical study 30 July 2022 Pages: 11 - 11

12. TNF-α inhibitors: risk of hypoglycaemia

    Clinical study 30 July 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 30 July 2022 Pages: 13 - 13

14. Acacia-catechu/scutellaria-baicalensis

    Case report 30 July 2022 Pages: 14 - 14

15. Acetazolamide

    Case report 30 July 2022 Pages: 15 - 15

16. Acetazolamide/prednisolone

    Case report 30 July 2022 Pages: 16 - 16

17. Aciclovir/steroids

    Case report 30 July 2022 Pages: 17 - 17

18. Acitretin/ciclosporin

    Case report 30 July 2022 Pages: 18 - 18

19. Aconitum

    Case report 30 July 2022 Pages: 19 - 19

20. Ad26.cov2-s

    Case report 30 July 2022 Pages: 20 - 20

21. Ad26.cov2-s

    Case report 30 July 2022 Pages: 21 - 21

22. Ad26.cov2-s/elasomeran

    Case report 30 July 2022 Pages: 22 - 22

23. Ad26.COV2-S/elasomeran/tozinameran

    Case report 30 July 2022 Pages: 23 - 24

24. Ad26.COV2-S/Rituximab

    Case report 30 July 2022 Pages: 24 - 24

25. Adalimumab

    Case report 30 July 2022 Pages: 25 - 25

26. Adalimumab/antibacterials/isotretinoin

    Case report 30 July 2022 Pages: 26 - 26

27. Adalimumab/capecitabine interaction

    Case report 30 July 2022 Pages: 27 - 27

28. Adalimumab/secukinumab

    Case report 30 July 2022 Pages: 28 - 28

29. Afatinib

    Case report 30 July 2022 Pages: 29 - 29

30. Aflibercept

    Case report 30 July 2022 Pages: 30 - 30

31. Alemtuzumab

    Case report 30 July 2022 Pages: 31 - 31

32. Alirocumab/prednisone

    Case report 30 July 2022 Pages: 32 - 32

33. Allopurinol/ciclosporin

    Case report 30 July 2022 Pages: 33 - 33

34. Aloe vera/dioctyl sulfosuccinic acid/magnesium hydroxide

    Case report 30 July 2022 Pages: 34 - 34

35. Alpelisib

    Case report 30 July 2022 Pages: 35 - 35

36. Alteplase

    Case report 30 July 2022 Pages: 36 - 36

37. Amantadine/lisdexamfetamine/risperidone

    Case report 30 July 2022 Pages: 37 - 37

38. Ambrisentan/sildenafil

    Case report 30 July 2022 Pages: 38 - 38

39. Amiodarone

    Case report 30 July 2022 Pages: 39 - 39

40. Amiodarone

    Case report 30 July 2022 Pages: 40 - 40

41. Amiodarone/epinephrine

    Case report 30 July 2022 Pages: 41 - 41

42. Amiodarone/procainamide

    Case report 30 July 2022 Pages: 42 - 42

43. Amitriptyline/ascorbic-acid/gabapentin/lidocaine

    Case report 30 July 2022 Pages: 43 - 43

44. Amitriptyline/paroxetine

    Case report 30 July 2022 Pages: 44 - 44

45. Amoxicillin/clarithromycin/rabeprazole

    Case report 30 July 2022 Pages: 45 - 45

46. Amoxicillin/clavulanic acid/cisatracurium besilate/general anaesthetics

    Case report 30 July 2022 Pages: 46 - 46

47. Amoxicillin/clavulanic-acid

    Case report 30 July 2022 Pages: 47 - 47

48. Amoxicillin/clavulanic-acid/ertapenem

    Case report 30 July 2022 Pages: 48 - 48

49. Amphotericin B liposomal/sodium stibogluconate

    Case report 30 July 2022 Pages: 49 - 49

50. Amphotericin-B-liposomal

    Case report 30 July 2022 Pages: 50 - 50